Publications
Study investigated whether atomoxetine, a selective norepinephrine re-uptake inhibitor with a primary indication for attention, would improve attention impairment following traumatic brain injury (TBI). Fifty-five adults with a history of a single moderate-to-severe TBI for at least 1 year and self-reported complaints of attention difficulties received 40 milligrams of ...